NKGN NKGen Biotech Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NKGN

Price (delayed)

$1.395

Market cap

$31.81M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.38

Enterprise value

$51.46M

graf industrial corp is a blank check company. the company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business ...

Highlights
NKGen Biotech's gross profit has surged by 100% QoQ but it has shrunk by 100% YoY
The revenue has dropped by 100% year-on-year
The company's quick ratio has shrunk by 96% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://grafacq.com
Peers: OMER OMGA

Key stats

What are the main financial stats of NKGN
Market
Shares outstanding
22.81M
Market cap
$31.81M
Enterprise value
$51.46M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$82.2M
EBITDA
-$80.64M
Free cash flow
-$22M
Per share
EPS
-$5.38
Free cash flow per share
-$1.43
Book value per share
-$2.68
Revenue per share
$0
TBVPS
$1.06
Balance sheet
Total assets
$16.48M
Total liabilities
$75.17M
Debt
$19.92M
Equity
-$58.69M
Working capital
-$37.52M
Liquidity
Debt to equity
-0.34
Current ratio
0.05
Quick ratio
0.01
Net debt/EBITDA
-0.24
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-416%
Return on equity
N/A
Return on invested capital
-894.5%
Return on capital employed
N/A
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NKGN stock price

How has the NKGen Biotech stock price performed over time
Intraday
5.68%
1 week
-13.35%
1 month
-10%
1 year
-86.3%
YTD
-49.27%
QTD
-26.19%

Financial performance

How have NKGen Biotech's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$29.75M
Net income
-$82.95M
Gross margin
N/A
Net margin
N/A
NKGen Biotech's gross profit has surged by 100% QoQ but it has shrunk by 100% YoY
The revenue has dropped by 100% year-on-year
NKGen Biotech's net income has decreased by 47% QoQ
NKGN's operating income is down by 22% year-on-year and by 12% since the previous quarter

Growth

What is NKGen Biotech's growth rate over time

Valuation

What is NKGen Biotech stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
NKGen Biotech's EPS has decreased by 39% from the previous quarter and by 28% YoY
The company's equity fell by 44% QoQ
The revenue has dropped by 100% year-on-year

Efficiency

How efficient is NKGen Biotech business performance
NKGen Biotech's return on invested capital has shrunk by 116% QoQ
NKGen Biotech's ROA has decreased by 47% from the previous quarter

Dividends

What is NKGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NKGN.

Financial health

How did NKGen Biotech financials performed over time
The total assets is 78% smaller than the total liabilities
The current ratio has soared by 150% YoY but it has plunged by 81% from the previous quarter
The company's quick ratio has shrunk by 96% QoQ
The company's debt is 134% higher than its equity
NKGN's debt to equity has dropped by 104% year-on-year but it is up by 31% since the previous quarter
The company's debt has surged by 66% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.